I-SP-D was cleared with a half-life of 7 h from SP-D(Ϫ/Ϫ) mice vs. 13 h in SP-D(ϩ/ϩ) mice. Although initial incorporation and secretion rates for [ 3 H]palmitic acid and [
14 C]choline into Sat PC were similar, the labeled Sat PC was lost from the lungs of SP-D(ϩ/ϩ) mice more rapidly than from SP-D(Ϫ/Ϫ) mice. Clearance rates of intratracheal [ 3 H]dipalmitoylphosphatidylcholine were used to estimate net clearances of Sat PC, which were approximately threefold higher for alveolar and total lung Sat PC in SP-D(Ϫ/Ϫ) mice than in SP-D(ϩ/ϩ) mice. SP-D deficiency results in multiple abnormalities in surfactant forms and metabolism that cannot be attributed to a single mechanism. dipalmitoylphosphatidylcholine; surfactant protein A; surfactant protein B; surfactant protein C; surfactant protein D SURFACTANT PROTEIN (SP) D is a 43-kDa member of the collectin family of proteins that shares structural homology with SP-A and mannose binding protein (3) . In contrast to SP-A, SP-D does not interact with the major surfactant phospholipids and is not associated with lamellar bodies or tubular myelin. Based on in vitro studies, SP-D was thought to be primarily a host defense protein, and there was no direct evidence that SP-D contributed to surfactant function or homeostasis (19) . SP-D gene-targeted [(Ϫ/Ϫ)] mice survive and breed normally under laboratory conditions (2, 18) ; however, their lungs have marked increases in tissue and alveolar surfactant phospholipids. SP-D(Ϫ/Ϫ) mice also have increased numbers of enlarged foamy alveolar macrophages, changes in the structure of extracellular surfactant, enlarged type II cells with increased lamellar body number and size, and enlarged distal air spaces.
The pool sizes of surfactant lipids and proteins are regulated by the net contributions from synthesis, secretion, uptake and catabolism by macrophages, and reuptake by type II cells that recycle or catabolize surfactant components (35) . The factors that influence alveolar and tissue pools of surfactant components are poorly understood. The important role of granulocytemacrophage colony-stimulating factor (GM-CSF) signaling was demonstrated in GM-CSF-and common ␤-chain receptor-deficient mice that had an alveolar proteinosis characterized by increases in surfactant lipids and proteins, with a selective increase in SP-D (26) . Likewise, increased expression of interleukin-4 (IL-4) caused increased surfactant lipid and SP-A, SP-B, and SP-C content in transgenic mice. The largest change in the IL-4 mice was a 90-fold increase in SP-D (10) . In contrast, surfactant lipids were markedly increased in the lungs of SP-D(Ϫ/Ϫ) mice without substantial changes in the amounts of SPs relative to those in wild-type mice (18) . To better define the role of SP-D in surfactant homeostasis, we measured SP-A, SP-B, and SP-C, evaluated surfactant forms, and characterized the metabolism of Sat PC and SP-D in SP-D wild-type [(ϩ/ϩ)] and SP-D(Ϫ/Ϫ) mice in vivo.
MATERIALS AND METHODS
Mice. NIH Swiss black SP-D(ϩ/ϩ) and SP-D(Ϫ/Ϫ) mice were generated as previously described (18) and carried as breeding colonies in the vivarium at Children's Hospital (Cincinnati, OH) according to protocols approved by the Institutional Animal Care and Use Committee. Genotyping was performed by DNA blot analysis. All of the studies were performed with 7-to 9-wk-old mice except as indicated for selected experiments. Processing of tissue and biochemical determinations in SP-D(ϩ/ϩ) and SP-D(Ϫ/Ϫ) mice were performed simultaneously.
Sat PC pool sizes. Total lung Sat PC pools (calculated as mol/kg body wt) were measured in 7 SP-D(ϩ/ϩ) and 11 SP-D(Ϫ/Ϫ) mice fetuses 16.5 days after conception. Measurements of Sat PC pool sizes were also taken in 27 SP-D(ϩ/ϩ) and 35 SP-D(Ϫ/Ϫ) mice from 4 litters/genotype at 2 days of age and in separate groups of 8 mice aged 7-140 days. Sat PC in alveolar lavage fluid and lung tissue (after alveolar lavage) was measured at 21, 56, and 140 days of age. Each mouse was deeply anesthetized with intraperitoneal pentobarbital sodium, and the distal aorta was cut to exsanguinate the animal (11) . After the chest was opened, a 20-gauge blunt needle was tied into the trachea, and 0.9% NaCl was flushed into the airway until the lungs were fully expanded. The fluid was then withdrawn by syringe three times for each aliquot. The saline lavage was repeated five times and the samples were pooled, and the volume was measured. The lavaged lung tissue was homogenized in 0.9% NaCl. Aliquots of alveolar lavage fluid and the lung homogenates were extracted with chloroform-methanol (2:1), and Sat PC was isolated with the technique of Mason et al. (20) . The amount of Sat PC was measured by phosphorus assay (1) .
SP pool sizes. The SPs in fluid from the alveolar washes and large-aggregate surfactant were analyzed by Western blot in six mice from each genotype. Samples containing 1.35 nmol of Sat PC were used for analysis of SP-A, and samples containing 2.7 nmol of Sat PC were used for analysis of SP-C. Proteins were separated by SDS-PAGE in the presence of ␤-mercaptoethanol. For SP-B analysis, aliquots containing 0.27 nmol of Sat PC were electrophoresed under nonreducing conditions. SP-A was separated on 8-16% acrylamide gels with Tris-glycine buffer. SP-B and SP-C samples were separated on 10-20% acrylamide gels with Tricine buffer (Novex, San Diego, CA). After electrophoresis, proteins were transferred to nitrocellulose paper (Schleicher & Schuell, Keene, NH) for SP-A or to polyvinylidene difluoride paper (Bio-Rad, Hercules, CA) for SP-B and SP-C. Immunoblot analysis was carried out with the following dilutions of antisera: 1:25,000 for guinea pig anti-rat SP-A; 1:10,000 for rabbit anti-bovine SP-B; and 1:25,000 for rabbit anti-recombinant human SP-C (21, 30, 34) . Appropriate peroxidase-conjugated secondary antibodies were used at 1:10,000 dilutions. Immunoreactive bands were detected with enhanced chemiluminescence (ECL) reagents (Amersham, Chicago, IL). Protein bands were quantitated by densitometric analyses with Alpha Imager 2000 documentation and analysis software (Alpha Innotech, San Leandro, CA).
Precursor incorporation into Sat PC and secretion. SP-D(ϩ/ϩ) and SP-D(Ϫ/Ϫ) mice were given intraperitoneal injections of 8 l saline/g body wt containing 0.5 Ci (11) . The palmitic acid was stabilized in solution with 5% human serum albumin (17) . Groups of six to nine mice were killed at preselected times, and alveolar lavage fluid was recovered from each animal. Lung tissue was placed in 0.9% NaCl. Sat PC was isolated from the alveolar lavage fluid and homogenized lung tissue as described in Sat PC pool sizes, and radioactivity was measured. The percent secretion of labeled Sat PC was calculated as the percent of radioactivity in alveolar Sat PC relative to the total radioactivity in the alveolar lavage fluid plus lung tissue.
Clearance of dipalmitoylphosphatidylcholine. Mice were anesthetized with methoxyflurane and orally intubated with a 25-gauge animal feeding needle. Each mouse received 60 l of saline containing 0.5 Ci of Aggregate forms of alveolar surfactant. Large-and smallaggregate surfactants were isolated from the alveolar lavage fluid of eight SP-D(ϩ/ϩ) and six SP-D(Ϫ/Ϫ) mice by centrifugation at 40,000 g for 15 min over a 0.8 M sucrose in 0.9% NaCl cushion (13) . The large-aggregate surfactant was collected from the 0.8 M sucrose interface. The supernatant contained small-aggregate surfactant. The amount of Sat PC was measured for both large-and small-aggregate surfactant, and the percent of Sat PC in large-aggregate surfactant in the total alveolar Sat PC was calculated. The Sat PC was also measured in the cell pellets at the bottom of the tubes under the sucrose step gradient.
Conversion of large-aggregate to small-aggregate surfactant. Large-aggregate surfactant (0.1 mol of Sat PC) was mixed with 2 ml of Tris buffer in a capped 12 ϫ 75-mm polystyrene tube, and surface area cycling was performed as previously described (7, 12) . Briefly, tubes were attached to the disk of Rototorque rotators (Cole-Parmer Instruments, Chicago, IL) in a 37°C incubator. Five tubes each for SP-D(ϩ/ϩ) and SP-D(Ϫ/Ϫ) mice were rotated for 6 h at 40 rotations/min to change the surface area from 1.1 to 9.0 cm 2 two times per cycle. One tube for each group was incubated for the same time period without rotation. The large-and small-aggregate surfactants were isolated by centrifugation at 40,000 g for 15 min. The large-aggregate surfactant in the pellet and the residual small-aggregate surfactant in the supernatants were measured by phosphorus assay (1) .
Surface activity. The surface properties of three pools (3 mice/pool) of large-aggregate surfactant isolated from SP-D(ϩ/ϩ) and SP-D(Ϫ/Ϫ) mice were measured with the captive bubble surfactometer (31) . Aliquots of the surfactant pools were organic solvent extracted, and Sat PC concentrations were measured as described in Sat PC pool sizes. The concentration of each pool was adjusted to 3 mol Sat PC/l, and 3 l of the native surfactant were applied to the air interface of a 25-l bubble. The surface tension was measured every second for 5 s and at 10, 20, 30, and 60 s, and bubble pulsation was started. The minimum surface tensions after 65% volume reductions of the bubbles were measured for 5th and 10th pulsations.
Data analysis. All values are given as means Ϯ SE. Differences between the two groups were determined by a twotailed Student's t-test. The between-group comparisons were made by analysis of variance followed by the Student-New-man-Keuls multiple comparison procedure. Curves were fit with the use of linear regression. SP pool sizes. The amounts of the SPs in the fluid from the alveolar washes from SP-D(Ϫ/Ϫ) mice were estimated by Western blot (Fig. 2A) . In SP-D(Ϫ/Ϫ) mice, SP-A content was decreased to 12% of normal values. SP-B content was increased twofold, and SP-C was unchanged. Because alveolar Sat PC was increased 2.3-fold in the SP-D(Ϫ/Ϫ) mice used for these measurements, the contents of the SPs are also expressed relative to Sat PC (Fig. 2B) . In SP-D(Ϫ/Ϫ) mice, the amount of SP-A was decreased to 6 Ϯ 3% of the normal value, the amount of SP-B was unchanged, and there was 52 Ϯ 7% of the normal amount of SP-C relative to Sat PC.
RESULTS

Sat
Precursor incorporation into Sat PC. The large aggregates from SP-D(Ϫ/Ϫ) mice converted with surface area cycling to small-aggregate surfactant faster than did the surfactant from SP-D(ϩ/ϩ) mice. Eighty-nine percent of the large-aggregate surfactant from SP-D(Ϫ/Ϫ) mice converted to small-aggregate forms after 6 h of surface area cycling (Fig. 8B) . The large aggregates were not converted to small aggregates (Ͼ96% recovery) when the tubes were kept at 37°C for 6 h without cycling. The relative amounts of SPs were estimated in large-aggregate surfactants by Western blot (Fig. 8C) . The concentrations of SP-A and SP-C were markedly decreased in largeaggregate surfactant from SP-D(Ϫ/Ϫ) mice. There were no differences in concentration of SP-B relative to Sat PC.
Surface activity. Large-aggregate surfactants from SP-D(ϩ/ϩ) and SP-D(Ϫ/Ϫ) mice reached equilibrium surface tension within 10 s. The equilibrium surface tension was 21.6 Ϯ 0.30 mN/m (n ϭ 3 pools of surfac- 
DISCUSSION
We found a number of changes in alveolar surfactant that may contribute to the altered homeostasis in SP-D(Ϫ/Ϫ) mice. The age-independent three-to fourfold increase in both alveolar and total lung Sat PC is associated with an increased relative amount of smallaggregate surfactant. The large-aggregate surfactant fraction converts more rapidly to small-aggregate surfactant when the surface area is cycled. The ratios of SP-A and SP-C to Sat PC are decreased, and the ratio of SP-B to Sat PC is not changed in the large-aggregate surfactant of SP-D(Ϫ/Ϫ) relative to that in SP-D(ϩ/ϩ) control mice. Lower SP-A might result in increased small-aggregate surfactant, which is the form preferentially taken up by type II cells (9) . We interpret the metabolic data based on the assumption that precursor These results extend the descriptions of the first two reports (2, 18) of separately generated SP-D-deficient mice with the use of comparable transgenic technologies. The only substantive difference between the mouse described by Botas et al. (2) and the mouse that was reported by Korfhagen et al. (18) was the content of SPs in alveolar lavage fluid. They (18) found a modest decrease in SP-A mRNA and decreased total SP-A in fluid from alveolar washes. Botas et al. (2) reported a 2.4-fold increase in SP-A, a 6-fold increase in SP-B, and no change in mRNAs for the SPs in animals of a similar age of 8 wk. Therefore, we further evaluated the amounts of the SPs in alveolar lavage fluid and related those amounts to the amount of Sat PC. Relative to Sat PC, SP-A in lavage fluid of SP-D(Ϫ/Ϫ) mice was only 6% of the normal amount, SP-B was present in normal amounts, and SP-C was decreased by 50%. This analysis emphasizes the ratio of the SPs to Sat PC because surfactant function is presumably dependent on the SP-to-lipid ratios (25, 32) . Because the small-aggregate surfactant does not contain SPs in appreciable amounts and the small-aggregate pool is increased in SP-D(Ϫ/Ϫ) mice relative to that in SP-D(ϩ/ϩ) mice, we further evaluated the ratio of SPs to Sat PC in the large-aggregate surfactant. The large-aggregate surfactant is the biophysically active fraction of surfactant and the presumed precursor pool for the surface film (36) . In large-aggregate surfactant, the SP-A-and SP-C-to-Sat PC ratios are 25 and 30%, respectively, of the control values in SP-D(Ϫ/Ϫ) mice. The ratio is unchanged for SP-B.
The structure of the large-aggregate surfactant from SP-D(Ϫ/Ϫ) mice was previously described as having enlarged and dense phospholipid arrays with less tubular myelin compared with that from SP-D(ϩ/ϩ) mice (18) . These structures are similar to those described for SP-A(Ϫ/Ϫ) mice except that those mice have no tubular myelin (12) . Although SP-D can cause the formation of tubular myelin-like structures with surfactant lipids in vitro (24) , the abnormal structures probably result from the low SP-A-to-Sat PC ratios. The functional consequences are an increased rate of conversion from large-aggregate to small-aggregate surfactant with surface area cycling. Conversion rates increased in surfactant that lacked SP-A (12), and conversion rates decreased when excess SP-A was added to rabbit surfactant (8) . Therefore, it is reasonable to attribute the increased conversion from large-aggregate to smallaggregate surfactant to the very low SP-A content of large-aggregate surfactant from SP-D(Ϫ/Ϫ) mice. Despite the low SP-A-and SP-C-to-Sat PC ratios, surface activity of large-aggregate surfactant isolated from SP-D(Ϫ/Ϫ) mice was similar to surfactant from normal SP-D(ϩ/ϩ) mice. The normal SP-B-to-Sat PC ratio in large-aggregate surfactant from SP-D(Ϫ/Ϫ) mice was sufficient for normal surface activity. SP-C is not required for surface activity if SP-B is present in normal amounts (29) .
Our studies of the metabolism of Sat PC demonstrate very complex alterations in SP-D(Ϫ/Ϫ) mice. On the anabolic side of the equation, type II cell numbers are probably similar in SP-D(Ϫ/Ϫ) and SP-D(ϩ/ϩ) mice, although formal morphometrics have not been performed. The mice that we studied at ϳ8 wk of age do not have much of the emphysema that develops markedly after 12 wk of age (33) . Incorporation of the precursors palmitic acid and choline into lung Sat PC over the initial hours after precursor administration was similar for SP-D(Ϫ/Ϫ) and SP-D(ϩ/ϩ) animals. If it is assumed that precursor pools are similar, this measurement is the in vivo equivalent of comparable synthetic rates for Sat PC. Similarly, the initial percent secretion of the newly synthesized radiolabeled Sat PC is comparable for the mice despite the description of enlarged lamellar bodies in some type II cells in SP-D(Ϫ/Ϫ) mice (2) . The incorporation and secretion data for the first 16 h after precursor administration indicate comparable anabolism in SP-D(ϩ/ϩ) and SP-D(Ϫ/Ϫ) mice.
As anticipated, palmitic acid-labeled Sat PC is lost from the alveolar lavage fluid and total lungs, indicating catabolism of endogenously synthesized Sat PC in SP-D(ϩ/ϩ) mice. This result has been replicated by multiple measurements (10, 13) . In contrast, palmitic acid-labeled Sat PC continues to accumulate in alveolar washes in SP-D(Ϫ/Ϫ) mice. There also is less loss of palmitic acid from the lungs of SP-D(Ϫ/Ϫ) mice. This abnormality is magnified with the choline label, where choline labeling of Sat PC in both alveolar lavage fluid and total lungs continues to increase for up to 72 h. The mice were given the precursor by intraperitoneal injection because we found more uniform labeling between animals injected in this fashion than those measured with intravascular precursor injections (13) , and intraperitoneal labeling was used previously for similar metabolic studies in mice by Gross et al. (6) . However, intraperitoneal labeling will result in less rapid clearance of the intravascular label and preferential labeling of the liver. Some label will enter the lungs at later times, and the stability and pool sizes of choline precursors in the lung are not known. In wild-type mice, catabolism of the initially synthesized Sat PC is in excess of any new label entering the lungs, and net catabolic activity is measured. If it is assumed that new label entering the lungs is comparable in SP-D(ϩ/ϩ) and SP-D(Ϫ/Ϫ) mice, the conclusion is that there is less catabolism of endogenously synthesized Sat PC in SP-D(Ϫ/Ϫ) than in SP-D(ϩ/ϩ) mice because labeled Sat PC continues to accumulate. The persistence of the radiolabel in Sat PC suggests that endogenously synthesized Sat PC is degraded more slowly in SP-D(Ϫ/Ϫ) mice than in their SP-D(ϩ/ϩ) counterparts. The caveat is that the total lung Sat PC pool size is three to four times higher in SP-D(Ϫ/Ϫ) than in SP-D(ϩ/ϩ) mice. The larger pool sizes may promote an increased catabolic rate by mass action. If this endogenously synthesized pool mixes uniformly with the total pool, the net catabolic rate (in mol Sat PC/kg) may not be very different.
Alveolar clearance and catabolism also were measured after intratracheal injection of radiolabeled DPPC. These measurements avoided the problem of the radiolabel entering the lungs at late times but depended on the tracers mixing with the alveolar pool (14) . In normal animals, metabolic variables estimated by precursor measurements and from intratracheal injections of labeled DPPC are similar (15) . Alveolar clearance of DPPC was slower in SP-D(Ϫ/Ϫ) mice than in SP-D(ϩ/ϩ) mice, with biological half-life values of 5.1 and 2.8 h, respectively. If it is assumed that the clearance of the tracer and of the total alveolar pool are the same, discounting recycling, and noting that the alveolar Sat PC pool size is three to four times larger in SP-D(Ϫ/Ϫ) mice, the amount of Sat PC cleared would be 0.2 mol/h for SP-D(ϩ/ϩ) and 0.6 mol/h for SP-D(Ϫ/Ϫ) mice. Therefore, the SP-D(Ϫ/Ϫ) mice clear more Sat PC per unit time than SP-D(ϩ/ϩ) mice. Loss of the radiolabel to macrophages is a relatively constant percentage of the alveolar pool, demonstrating no accumulation of DPPC in macrophages. This labeling pattern was described previously in rabbits and provides no information about the catabolic activity of the macrophages (28) . Alveolar clearance would appear delayed if a high percentage of the DPPC were recycled. The recycling efficiency in wild-type mice was estimated to be ϳ50% (6).
Total lung catabolic activity can be estimated by the loss of DPPC from the lungs. Intact DPPC does not leave the lungs in appreciable amounts (23) . The biological half-life of 15 h for SP-D(Ϫ/Ϫ) mice was somewhat longer than the 9 h measured for SP-D(ϩ/ϩ) mice. However, the three-to fourfold larger Sat PC pool sizes in SP-D(Ϫ/Ϫ) compared with SP-D(ϩ/ϩ) mice resulted in catabolic rates of 1.9 and 0.6 mol/h, respectively, demonstrating threefold higher catabolic activity in the SP-D(Ϫ/Ϫ) group.
These metabolic studies resulted in a conundrum because anabolism (incorporation and secretion) is comparable in SP-D(ϩ/ϩ) and SP-D(Ϫ/Ϫ) mice, and endogenously synthesized Sat PC likely is catabolized more slowly in SP-D(Ϫ/Ϫ) than in SP-D(ϩ/ϩ) animals. In contrast, the intratracheal clearance studies indicate more rapid net catabolism of the larger pools in the SP-D(Ϫ/Ϫ) mice. These measurements have not considered recycling. The accumulation of lipids in the air spaces of SP-D(Ϫ/Ϫ) mice is not uniform, based on histopathology, nor is the distribution of cells with large lamellar bodies (2, 18) . It is possible that the intravascular precursors are selectively evaluating different cell populations and that intratracheal DPPC is measuring clearance and catabolism for only part of the alveolar pool.
The contribution of recycling to the increased surfactant pool sizes is not known, but increased recycling might occur because of the increased alveolar smallaggregate surfactant pool. The small-aggregate surfactant thought to be the catabolic form for the phospholipids is preferentially taken up by type II cells in vitro (9) . Further studies will be required to sort out the relationship between the endogenous incorporation data and the enlarged lamellar bodies in type II cells. The increased numbers of lipid-laden macrophages will also no doubt contribute to the overall metabolic abnormalities in these mice. Alveolar macrophages contribute ϳ20% to the overall catabolic rate of surfactant in adult rabbit lungs (27) , but the macrophage contribution in mice is not known.
Animal models of increased surfactant phospholipid and increased SP pool sizes include silica and mineral dust exposure (4), the severe-combined immunodeficient mouse (16) , gene-targeted disruption of the GM-CSF or GM-CSF receptor ␤/C gene (13, 26) , and overexpression of IL-4 (10). Increased surfactant phospholipid in SP-D(Ϫ/Ϫ) mice was not associated with increased amounts of SPs, distinguishing this phenotype from the alveolar lipoproteinosis syndromes. Each of the models of alveolar proteinosis has different alterations in metabolic pathways that yield a similar phenotype. For example, GM-CSF deficiency and GM-CSF receptor inactivation result primarily from a decrease in phospholipid and SP catabolism (13, 26) . Mice with defective GM-CSF signaling also accumulate large amounts of SP-D in the air spaces. In contrast, SP-D was cleared relatively rapidly in SP-D(Ϫ/Ϫ) mice. Those that overexpress IL-4 have alveolar proteinosis primarily because of increased precursor incorporation and secretion rates (10) . In these models, the ratio of SPs to Sat PC is normal or increased. The SP-D(Ϫ/Ϫ) phenotype is unique because of the decreased SP-A and SP-C relative to Sat PC.
An absolute SP-D(Ϫ/Ϫ) deficiency results in multiple abnormalities in the surfactant system. In contrast, SP-D(ϩ/-) mice have normal surfactant lipid pool sizes, and mice that overexpress SP-D also have normal surfactant pool sizes, indicating that the phenotype is sensitive to the amount of SP-D (5). SP-D deficiency alters surfactant lipid, SP-A, and SP-C pools and metabolism by unknown mechanisms.
